Gapping up
In reaction to strong earnings/guidance: CY +1.1% (also announced that Brad Buss, Executive Vice President and Chief Financial Officer is retiring from Cypress after eight years of service), RECN +0.3%.
Select battery related names showing strength: PLUG +5.6% (acquires ReliOn for $4 mln in stock; expected to be accretive to earnings in 2015 ), KNDI +2%, BLDP 2.5%, TSLA +1.2% (to appeal ban on NJ direct sales, according to reports out yesterday mid session).
Select oil/gas related names showing strength: NBR +1.7%, ESV +1.7%, CHK +0.8%, WFT +0.7% (approves change of jurisdiction of incorporation from Switzerland to Ireland), DVN +0.6%, NFX +0.6% (upgraded to Buy from Neutral at UBS).
Other news: AMRS +18.4% (Amyris and BASF reach agreement for strain engineering collaboration), CYTR +8.4% (to present updated Aldoxorubicin preclinical glioblastoma study results; support continued development of Aldoxorubicin as treatment for relapsed glioblastoma ), WPCS +6.6% (enters into definitive agreement to sell its Seattle Operations for ~ $2.7 mln), ISR +5.8% (continued strength), MNGA +5.4% (Expands into Georgia with New Distributor), ACTG +4.2% (announces settlements and license agreements), EJ +3.6% (announced that affiliate of its subsidiary Leju signed a partnership agreement with Zillow), MCP +3.5% (still checking), IRBT +2.3% (announces $50 mln stock repurchase program), CTRP +2.2% (announces up to $600 mln share repurchase program), ONNN +2.1% ( to Acquire Truesense Imaging for ~$92 mln in cash), MNKD +2.1% (continued strength), GILD +1.9% (announces results from Phase 3 Study of Sofosbuvir Among Hepatitis C Patients in Japan; The study met its primary efficacy endpoint), BBRY +1.8% (still checking), WBAI +1.5% (still checking), SUNE +1.3% (S.A.C. Capital cuts passive stake to 0.2%, down from 5.3% on 2/14 - amended 13G filing ), FIO +1.2% (Fusion-io collaborates with Oracle (ORCL) to double usable capacity for MySQL), ALLT +1.2% (receives $5 mln purchase order from a Tier-1 mobile and fixed operator), NVS +1.2% (announces data on 19 compounds at AACR highlight strong cancer pipeline across multiple molecular targets and biological pathways), HE+1.1% (issues statement: 'Board of directors has not cut the dividend, nor is a dividend cut currently contemplated'), PACW +1% (PACW to replace MANT in the S&P MidCap 400), CHL +1% (still checking), JKS +0.6% (signs RMB241.4 Million Loan Agreement with China Development Bank for Two PV Solar Projects), COST +0.1% (positive mention on Mad Money).
Analyst comments: OPEN +2% (upgraded to Buy from Neutral at Citigroup), MON +1.6% (upgraded to Overweight from Neutral at JP Morgan), KKR +0.5% (initiated with a Outperform at Bernstein), INTC +0.5% (resumed with an Overweight from Neutral at Piper Jaffray ), NXPI +0.3% (tgt raised to $76 from $60 at BofA/Merrill)
Select battery related names showing strength: PLUG +5.6% (acquires ReliOn for $4 mln in stock; expected to be accretive to earnings in 2015 ), KNDI +2%, BLDP 2.5%, TSLA +1.2% (to appeal ban on NJ direct sales, according to reports out yesterday mid session).
Select oil/gas related names showing strength: NBR +1.7%, ESV +1.7%, CHK +0.8%, WFT +0.7% (approves change of jurisdiction of incorporation from Switzerland to Ireland), DVN +0.6%, NFX +0.6% (upgraded to Buy from Neutral at UBS).
Other news: AMRS +18.4% (Amyris and BASF reach agreement for strain engineering collaboration), CYTR +8.4% (to present updated Aldoxorubicin preclinical glioblastoma study results; support continued development of Aldoxorubicin as treatment for relapsed glioblastoma ), WPCS +6.6% (enters into definitive agreement to sell its Seattle Operations for ~ $2.7 mln), ISR +5.8% (continued strength), MNGA +5.4% (Expands into Georgia with New Distributor), ACTG +4.2% (announces settlements and license agreements), EJ +3.6% (announced that affiliate of its subsidiary Leju signed a partnership agreement with Zillow), MCP +3.5% (still checking), IRBT +2.3% (announces $50 mln stock repurchase program), CTRP +2.2% (announces up to $600 mln share repurchase program), ONNN +2.1% ( to Acquire Truesense Imaging for ~$92 mln in cash), MNKD +2.1% (continued strength), GILD +1.9% (announces results from Phase 3 Study of Sofosbuvir Among Hepatitis C Patients in Japan; The study met its primary efficacy endpoint), BBRY +1.8% (still checking), WBAI +1.5% (still checking), SUNE +1.3% (S.A.C. Capital cuts passive stake to 0.2%, down from 5.3% on 2/14 - amended 13G filing ), FIO +1.2% (Fusion-io collaborates with Oracle (ORCL) to double usable capacity for MySQL), ALLT +1.2% (receives $5 mln purchase order from a Tier-1 mobile and fixed operator), NVS +1.2% (announces data on 19 compounds at AACR highlight strong cancer pipeline across multiple molecular targets and biological pathways), HE+1.1% (issues statement: 'Board of directors has not cut the dividend, nor is a dividend cut currently contemplated'), PACW +1% (PACW to replace MANT in the S&P MidCap 400), CHL +1% (still checking), JKS +0.6% (signs RMB241.4 Million Loan Agreement with China Development Bank for Two PV Solar Projects), COST +0.1% (positive mention on Mad Money).
Analyst comments: OPEN +2% (upgraded to Buy from Neutral at Citigroup), MON +1.6% (upgraded to Overweight from Neutral at JP Morgan), KKR +0.5% (initiated with a Outperform at Bernstein), INTC +0.5% (resumed with an Overweight from Neutral at Piper Jaffray ), NXPI +0.3% (tgt raised to $76 from $60 at BofA/Merrill)